OLIVE OIL; SOYBEAN OIL - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for olive oil; soybean oil and what is the scope of freedom to operate?

Olive oil; soybean oil is the generic ingredient in one branded drug marketed by Baxter Hlthcare Corp and is included in one NDA. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for OLIVE OIL; SOYBEAN OIL

US Patents:	0
Tradenames:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Clinical Trials:	70
DailyMed Link:	OLIVE OIL; SOYBEAN OIL at DailyMed

DrugPatentWatch^® Estimated Loss of Exclusivity (LOE) Date for OLIVE OIL; SOYBEAN OIL

Generic Entry Date for OLIVE OIL; SOYBEAN OIL^: ⤷ Sign Up* Constraining patent/regulatory exclusivity: NEW PATIENT POPULATION Dosage: EMULSION;INTRAVENOUS

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for OLIVE OIL; SOYBEAN OIL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Medesis Pharma SA	Phase 1/Phase 2
Hackensack Meridian Health	Phase 1
Assiut University	N/A

See all OLIVE OIL; SOYBEAN OIL clinical trials

Pharmacology for OLIVE OIL; SOYBEAN OIL

Drug Class	Lipid Emulsion

Anatomical Therapeutic Chemical (ATC) Classes for OLIVE OIL; SOYBEAN OIL

A06AG	Enemas
A06A	DRUGS FOR CONSTIPATION
A06	DRUGS FOR CONSTIPATION
A	Alimentary tract and metabolism

US Patents and Regulatory Information for OLIVE OIL; SOYBEAN OIL

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Baxter Hlthcare Corp	CLINOLIPID 20%	olive oil; soybean oil	EMULSION;INTRAVENOUS	204508-001	Oct 3, 2013		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for OLIVE OIL; SOYBEAN OIL

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Baxter Hlthcare Corp	CLINOLIPID 20%	olive oil; soybean oil	EMULSION;INTRAVENOUS	204508-001	Oct 3, 2013	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.